Clinical Trial

Published on 09 Mar 2023

Evaluating the efficacy of inhaled amikacin as an adjunct to intravenous combination therapy (ceftazidime and amikacin) in pediatric cystic fibrosis pulmonary exacerbation

in Pharmacology of Infectious Diseases

Amin Rakhshan
Nazanin Farahbakhsh
Ghamartaj Khanbabaee
Seyed Ahmad Tabatabaii
Saeed Sadr
Maryam Hassanzad
Mohammad Sistanizad
Farzaneh Dastan
Mahmoud Hajipour
Amir Reza Bahadori

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1130374

3,522 views
1 citation

Review

Published on 08 Mar 2023

Ebanga™: The most recent FDA-approved drug for treating Ebola

in Pharmacology of Infectious Diseases

Elahe Taki
Roya Ghanavati
Tahereh Navidifar
Shirin Dashtbin
Mohsen Heidary
Marjan Moghadamnia

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1083429

10,085 views
9 citations

Original Research

Published on 02 Mar 2023

Computational and experimental studies of salvianolic acid A targets 3C protease to inhibit enterovirus 71 infection

in Pharmacology of Infectious Diseases

Sai Shi
Lei Xie
Sen Ma
Binghong Xu
Hailong An
Sheng Ye
Yaxin Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1118584

2,235 views

Original Research

Published on 02 Mar 2023

The impact of pharmacist early active consultation (PEAC) on multidrug resistance organism treatment outcomes: A prospective historically controlled study

in Pharmacology of Infectious Diseases

Qian Du
Xin Xi
Jie Dong
Tongyan Zhang
Dongxuan Li
Yuzhu Dong
Wenjun Li
Guili Huang
Jun Zhu
Hailong Ran

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1128219

1,187 views
1 citation

Review

Published on 02 Mar 2023

Barriers and facilitators to maintaining a high level of polypharmacy adherence in people living with HIV: A scoping review

in Pharmacology of Infectious Diseases

Jiamin He
Zheng Zhu
Meiyan Sun
Xiaoning Liu
Junwen Yu
Lin Zhang
Hongzhou Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1013688

2,492 views
1 citation

Original Research

Published on 01 Mar 2023

Innovative, rapid, high-throughput method for drug repurposing in a pandemic—A case study of SARS-CoV-2 and COVID-19

in Pharmacology of Infectious Diseases

Shaibu Oricha Bello
Abdulmajeed Yunusa
Adamu Ahmed Adamu
Mustapha Umar Imam
Muhammad Bashir Bello
Abdulmalik Shuaibu
Ehimario Uche Igumbor
Zaiyad Garba Habib
Mustapha Ayodele Popoola
Chinwe Lucia Ochu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1130828

2,641 views
4 citations

Original Research

Published on 24 Feb 2023

Molluskicidal nanoemulsion of Neomitranthes obscura (DC.) N. Silveira for schistosomiasis control

in Pharmacology of Infectious Diseases

Leonardo da Silva Rangel
Francisco Paiva Machado
Raquel Amaral
Ana Cláudia Rodrigues Da Silva
Marcelo Guerra Santos
José Augusto Albuquerque Dos Santos
Natalia Lidmar Von Ranke
Carlos Rangel Rodrigues
Leandro Rocha
Robson Xavier Faria

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1078936

1,497 views

Review

Published on 24 Feb 2023

Antibacterial sensitizers from natural plants: A powerful weapon against methicillin-resistant Staphylococcus aureus

in Pharmacology of Infectious Diseases

Xiaoli Li
Yongqing Cai
Qinchuan Xia
Yongqun Liao
Rongxin Qin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1118793

3,750 views
4 citations

Clinical Trial

Published on 17 Feb 2023

Evaluation of noscapine-licorice combination effects on cough relieving in COVID-19 outpatients: A randomized controlled trial

in Pharmacology of Infectious Diseases

Saghar Barati
Faezeh Feizabadi
Hakimeh Khalaj
Hakimeh Sheikhzadeh
Hamid R. Jamaati
Hirad Farajidavar
Farzaneh Dastan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1102940

3,195 views
1 citation

Data Report

Published on 10 Feb 2023

The challenges of open data for future epidemic preparedness: The experience of the 2022 Ebolavirus outbreak in Uganda

in Pharmacology of Infectious Diseases

Francesco Branda
Ahmed Mahal
Antonello Maruotti
Massimo Pierini
Sandra Mazzoli

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1101894

3,002 views
6 citations

Original Research

Published on 07 Feb 2023

Variant-specific deleterious mutations in the SARS-CoV-2 genome reveal immune responses and potentials for prophylactic vaccine development

in Pharmacology of Infectious Diseases

Md. Aminul Islam
Shatila Shahi
Abdullah Al Marzan
Mohammad Ruhul Amin
Mohammad Nayeem Hasan
M. Nazmul Hoque
Ajit Ghosh
Abanti Barua
Abbas Khan
Kuldeep Dhama

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1090717

4,947 views
18 citations

Review

Published on 02 Feb 2023

Clofazimine for the treatment of tuberculosis

in Pharmacology of Infectious Diseases

Jacob A. M. Stadler
Gary Maartens
Graeme Meintjes
Sean Wasserman

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1100488

11,492 views
23 citations

Editorial

Published on 01 Feb 2023

Editorial: Cell cycle control as a new therapeutic approach for SARS-CoV-2 infection

in Pharmacology of Infectious Diseases

Roberta Rizzo
Francesca Caccuri
Giuseppe Valacchi
Giorgio Zauli

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1136277

898 views
1 citation

Original Research

Published on 01 Feb 2023

Incidence and potential risk factors for remdesivir-associated bradycardia in hospitalized patients with COVID-19: A retrospective cohort study

in Pharmacology of Infectious Diseases

Yazed Saleh Alsowaida
Fadi Shehadeh
Markos Kalligeros
Eleftherios Mylonakis

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1106044

2,472 views
8 citations

Editorial

Published on 26 Jan 2023

Editorial: New trends in natural product research for inflammatory and infectious diseases: Volume II

in Pharmacology of Infectious Diseases

Jaime Ribeiro-Filho
Yanna Carolina Ferreira Teles
John Ogbaji Igoli
Raffaele Capasso

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1144074

1,223 views
1 citation

Mini Review

Published on 24 Jan 2023

Phages against killer superbugs: An enticing strategy against antibiotics-resistant pathogens

in Pharmacology of Infectious Diseases

Bikash Baral

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1036051

6,176 views
9 citations

Navigation group

Articles

Evaluating the efficacy of inhaled amikacin as an adjunct to intravenous combination therapy (ceftazidime and amikacin) in pediatric cystic fibrosis pulmonary exacerbation

Ebanga™: The most recent FDA-approved drug for treating Ebola

Computational and experimental studies of salvianolic acid A targets 3C protease to inhibit enterovirus 71 infection

The impact of pharmacist early active consultation (PEAC) on multidrug resistance organism treatment outcomes: A prospective historically controlled study

Barriers and facilitators to maintaining a high level of polypharmacy adherence in people living with HIV: A scoping review

Innovative, rapid, high-throughput method for drug repurposing in a pandemic—A case study of SARS-CoV-2 and COVID-19

Molluskicidal nanoemulsion of Neomitranthes obscura (DC.) N. Silveira for schistosomiasis control

Antibacterial sensitizers from natural plants: A powerful weapon against methicillin-resistant Staphylococcus aureus

Evaluation of noscapine-licorice combination effects on cough relieving in COVID-19 outpatients: A randomized controlled trial

The challenges of open data for future epidemic preparedness: The experience of the 2022 Ebolavirus outbreak in Uganda

Variant-specific deleterious mutations in the SARS-CoV-2 genome reveal immune responses and potentials for prophylactic vaccine development

Clofazimine for the treatment of tuberculosis

Editorial: Cell cycle control as a new therapeutic approach for SARS-CoV-2 infection

Incidence and potential risk factors for remdesivir-associated bradycardia in hospitalized patients with COVID-19: A retrospective cohort study

Editorial: New trends in natural product research for inflammatory and infectious diseases: Volume II

Phages against killer superbugs: An enticing strategy against antibiotics-resistant pathogens